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ARTICLE
Mechanisms Underlying Heterogeneous Ca2+ Sparklet Activity 
in Arterial Smooth Muscle
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In arterial smooth muscle, single or small clusters of Ca2+ channels operate in a high probability mode, creating 
sites of nearly continual Ca2+ infl  ux (called “persistent Ca2+ sparklet” sites). Persistent Ca2+ sparklet activity varies 
regionally within any given cell. At present, the molecular identity of the Ca2+ channels underlying Ca2+ sparklets 
and the mechanisms that give rise to their spatial heterogeneity remain unclear. Here, we used total internal refl  ec-
tion fl  uorescence (TIRF) microscopy to directly investigate these issues. We found that tsA-201 cells expressing 
L-type Cavα1.2 channels recapitulated the general features of Ca2+ sparklets in cerebral arterial myocytes, including 
amplitude of quantal event, voltage dependencies, gating modalities, and pharmacology. Furthermore, PKCα 
  activity was required for basal persistent Ca2+ sparklet activity in arterial myocytes and tsA-201 cells. In arterial myo-
cytes, inhibition of protein phosphatase 2A (PP2A) and 2B (PP2B; calcineurin) increased Ca2+ infl  ux by evoking 
new persistent Ca2+ sparklet sites and by increasing the activity of previously active sites. The actions of PP2A and 
PP2B inhibition on Ca2+ sparklets required PKC activity, indicating that these phosphatases opposed PKC-medi-
ated phosphorylation. Together, these data unequivocally demonstrate that persistent Ca2+ sparklet activity is a 
fundamental property of L-type Ca2+ channels when associated with PKC. Our fi  ndings support a novel model in 
which the gating modality of L-type Ca2+ channels vary regionally within a cell depending on the relative activities 
of nearby PKCα, PP2A, and PP2B.
INTRODUCTION
During the myogenic response (Bayliss, 1902), smooth 
muscle lining the walls of resistance arteries respond 
to increased intravascular pressure by undergoing grad-
ual depolarization, thus increasing the open probability 
of dihydropyridine-sensitive, voltage-gated L-type Ca2+ 
channels located in the sarcolemma of arterial smooth 
muscle cells (Harder et al., 1987; Fleischmann et al., 
1994; Rubart et al., 1996; Knot and Nelson, 1998). In-
creased opening of L-type Ca2+ channels causes greater 
Ca2+ infl  ux that culminates in a global rise in intracellu-
lar Ca2+ ([Ca2+]i) and arterial constriction. Accordingly, 
by regulating the activity of L-type Ca2+ channels, 
smooth muscle cells are able to modulate [Ca2+]i, arte-
rial diameter, and therefore blood fl  ow.
We recently observed single and small clusters of 
seemingly coupled Ca2+ channels (presumably L-type) 
operating in a high activity gating mode that created 
  local areas of nearly continual Ca2+ infl  ux termed “per-
sistent Ca2+ sparklet” sites (Navedo et al., 2005). On the 
basis of these fi  ndings it was proposed that steady-state 
Ca2+ infl  ux in arterial smooth muscle occurs through 
persistent Ca2+ sparklet sites in combination with ran-
dom, infrequent openings of solitary L-type Ca2+ chan-
nels (Fleischmann et al., 1994; Rubart et al., 1996). At 
present, however, this “persistent Ca2+ sparklet model” 
remains largely untested.
The goal of this study was to address four funda-
mental, yet unresolved, issues raised by this provocative 
model. First, we investigated the molecular identity of 
the channels that underlie persistent Ca2+ sparklets. 
This is of particular importance because the conclusion 
that persistent Ca2+ sparklets are produced by the open-
ing of single, or small clusters, of L-type Ca2+ channels 
was based largely on pharmacological evidence (i.e., 
sensitivity to dihydropyridines), which is equivocal. 
  Second, we identifi  ed the minimal molecular compo-
nents required for persistent Ca2+ sparklet activity. 
Third, we investigated the mechanisms underlying 
  dynamic, regional variations in Ca2+ sparklet activity. 
Fourth, we examined the molecular identities of the sig-
naling molecules involved in the regional modulation 
of persistent Ca2+ activity.
Our data indicate that expression of PKCα and L-type 
Ca2+ (Cavα1.2) channels was suffi  cient to reproduce 
the basic features of persistent Ca2+ sparklet activity in a 
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heterologous expression system. This provides the fi  rst 
direct demonstration that Cavα1.2 channels underlie 
persistent Ca2+ sparklets in smooth muscle. Accord-
ingly, our data indicate, for the fi  rst time, that persistent 
Ca2+ sparklet activity is a fundamental feature of L-type 
Ca2+ channels (with PKCα), which suggests the intrigu-
ing possibility that persistent Ca2+ sparklets may be a 
general mechanism underlying steady-state Ca2+ entry 
in excitable cells. Finally, our data support the novel 
concept that subcellular compartmentalization of Ca2+ 
infl  ux via L-type Ca2+ channels is determined by the lo-
cal balance between PKCα and opposing phosphatase 
(protein phosphate 2A and 2B) activities.
MATERIALS AND METHODS
Isolation of Arterial Myocytes
Rats (Sprague-Dawley; ≈250 g) as well as wild type and PKCα 
knockout mice (≈25 g) (Braz et al., 2004) were euthanized in 
strict accordance to the regulations of the University of Washing-
ton Institutional Animal Care and Use Committee using a lethal 
dose of sodium pentobarbital (100 mg/kg, intraperitoneally). 
Myocytes were dissociated from cerebral arteries using standard 
enzymatic techniques described in detail elsewhere (Amberg and 
Santana, 2003). After dissociation, cells were maintained in a 
nominally Ca2+-free Ringer’s solution until used. Thapsigargin 
(1 μM) was included in all solutions to eliminate Ca2+ release 
from intracellular stores during experimentation.
Heterologous Expression of Cavα1.2 and PKCα in tsA-201 Cells
Cultures of tsA-201 cells were maintained in Dulbecco’s modifi  ed 
essential Media supplemented with 10% fetal bovine serum, 
l-glutamine (2 mM), and a 1% streptomycin and penicillin 
  solution. Cells were transiently transfected with the pcDNA clones 
of Cavα1.2, Cavβ3, Cavα2δ1 (a gift from D. Lipscombe, Brown 
University, Providence, RI), and the enhanced green fl  uorescent 
protein using Lipofectamine 2000. In some experiments, tsA-201 
cells were transfected with Cavα1.2 and accessory subunits as well 
as PKCα tagged with the enhanced green fl  uorescent protein 
(provided by J. Exton, Vanderbilt University, Nashville, TN). 
  Successfully transfected cells were identifi   ed on the basis of 
  enhanced green fl  uorescent protein fl  uorescence.
Electrophysiology
We used the conventional whole-cell patch-clamp technique to 
control membrane voltage using an Axopatch 200B amplifi  er. 
During experiments, cells were continuously superfused with a 
solution with the following constituents (in mM): 140 NMDG, 
5 CsCl, 1 MgCl2, 10 glucose, 10 HEPES, and 2 or 20 CaCl2 ad-
justed to pH 7.4. NMDG concentration was 120 mM when 20 mM 
CaCl2 was used. Pipettes were fi  lled with a solution composed of 
(in mM) 87 Cs-aspartate, 20 CsCl, 1 MgCl2, 5 MgATP, 10 HEPES, 
10 EGTA, and 0.2 Fluo-5F or Rhod-2 adjusted to pH 7.2 with 
CsOH. A voltage error of 10 mV attributable to the liquid junc-
tion potential was corrected for. In some experiments, Ca2+ cur-
rents were recorded and later analyzed using pCLAMP 9.0 
software. In these experiments, currents were sampled at 20 kHz 
and low pass fi  ltered at 2 kHz. All experiments were performed at 
room temperature (22–25°C).
Total Internal Reﬂ  ection Fluorescence (TIRF) Microscopy
Ca2+ sparklets were recorded using a through-the-lens TIRF mi-
croscope built around an inverted Olympus IX-70 microscope 
equipped with an Olympus PlanApo (60X, numerical aperture = 
1.45) oil-immersion lens and an XR Mega 10 intensifi  ed CCD 
camera (Solamere Technology Group). To monitor [Ca2+]i, cells 
were loaded with the calcium indicators Fluo-5F or Rhod-2. Rhod-2 
was used in all experiments in which the enhanced green fl  uores-
cent protein was expressed. Excitation of Fluo-5F and Rhod-2 was 
achieved with the 488- or 568-nm line of an argon or krypton 
  laser, respectively (Dynamic Lasers). Excitation and emission light 
was separated with the appropriate set of fi  lters. Images were 
  acquired at 30–90 Hz.
Background-subtracted fl  uorescence signals were converted 
to concentration units using the “Fmax” equation (Maravall 
et al., 2000):
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where F is fl  uorescence,  Fmax is the fl   uorescence intensity of 
Fluo-5N or Rhod-2 in the presence of a saturating free Ca2+ con-
centration, Kd is the dissociation constant of the fl  uorescence 
  indicator used (Fluo-5N = 1100 nM; Rhod-2 = 600 nM), and Rf 
(Fluo-5N = 210; Rhod-2 = 150) is this indicator’s Fmax/Fmin. Fmin 
is the fl  uorescence intensity of Fluo-5N or Rhod-2 in a solution 
where the Ca2+ concentration is 0. Kd and Rf values for Fluo-5N 
and Rhod-2 were determined in vitro using standard methods 
(Woodruff et al., 2002). Fmax was determined at the end of the 
  experiments by exposing cells to a solution to which the Ca2+ 
  ionophore ionomycin (10 μM) and 20 mM external Ca2+ had 
been added.
Ca2+ sparklets were detected and defi  ned for analysis using an 
automated algorithm written in IDL language. Ca2+ sparklets 
had an amplitude equal to or larger than the mean basal [Ca2+]i 
plus three times its standard deviation. For a [Ca2+]i elevation to 
be considered a sparklet, a grid of 3 × 3 contiguous pixels had to 
have a [Ca2+]i value at or above the amplitude threshold. These 
detection criteria for Ca2+ sparklets are similar to those used by 
other investigators (Cheng et al., 1999; Demuro and Parker, 
2004, 2005).
By simultaneously recording single Ca2+ channel currents and 
Ca2+ sparklets in arterial myocytes, we recently reported that 
at −70 mV and with 20 mM external Ca2+, a single Ca2+ chan-
nel current of ≈0.5 pA produced a Ca2+ sparklet of ≈37 nM 
(Navedo et al., 2005). As shown in Fig. S1 (see online supple-
mental material, available at http://www.jgp.org/cgi/content/
full/jgp200609519/DC1), an “all-points” histogram from rep-
resentative [Ca2+]i records obtained from arterial myocytes had 
multiple, clearly separated peaks and could be fi  t with the follow-
ing multi Gaussian function:
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where a and b are constants and [Ca2+]i and q are intracellular 
Ca2+ and the quantal unit of Ca2+ infl  ux, respectively. Using this 
analysis, and consistent with our previous study, we obtained a q 
value of 34 nM in the all-points histogram, a value that is similar 
to that obtained previously (see below). This analysis provides fur-
ther support to the hypothesis that Ca2+ sparklets are quantal in 
nature and that the size of Ca2+ sparklet depends on the number 
of quanta activated.
Analogous to single-channel data analysis, we determined the 
activity of Ca2+ sparklets by calculating the nPs of each sparklet 
site, where n is the number of quantal levels and Ps is the probabil-
ity that a quantal Ca2+ sparklet event is active. To do this, we used 
the single channel analysis module of pCLAMP 9.0. First, [Ca2+]i 
from previously identifi  ed sparklet sites were imported into this 
program and a baseline defi  ned. To estimate nPs, Ca2+ sparklet 
events were detected using pCLAMP’s “threshold detection   Navedo et al. 613
  analysis” using no duration constraints and a unitary Ca2+ eleva-
tion of 38 nM as a starting point for event detection (note that the 
amplitude of the unitary event was not fi  xed). Traces were then 
fi  tted with these initial parameters. Each one of the events de-
tected with this analysis were then cross-referenced with the origi-
nal image stack to verify that they met the amplitude and spatial 
criteria described above. Only Ca2+ infl  ux events that met the spa-
tial and amplitude criteria were used to estimate nPs for each ex-
perimental condition. An example of this type of analysis is shown 
in the online supplemental material (Fig. S2).
Amplitude histograms were constructed using the amplitudes 
of the detected Ca2+ sparklet events. The resulting histogram was 
fi   tted with the multicomponent Gaussian function described 
above, which allowed us to obtain an estimate of the amplitude of 
quantal Ca2+ sparklets under varied experimental conditions. It is 
important to note that the observation of multiple peaks and simi-
lar q values in our all-points and event histograms (e.g., Figs. 1–3 
and Fig. S1) indicate that the use of the event histogram for our 
quantal analysis is appropriate.
As previously reported (Navedo et al., 2005), Ca2+ sparklet ac-
tivity was bimodal in arterial myocytes and tsA-201 cells expressing 
Cavα1.2 and PKCα, with sites of low activity (nPs = 0.07 ± 0.01) 
and sites of high activity (nPs = 0.73 ± 0.7). Based on this behav-
ior, we grouped Ca2+ sparklets into three categories; silent (by de-
fault has an nPs of 0), low (nPs between 0 and 0.2), and high (nPs 
higher than 0.2). Note that a silent Ca2+ sparklet site represents a 
site that is ordinarily inactive, but can be activated by an agonist.
Chemicals and Statistics
All PKC inhibitors were acquired from Calbiochem. Cell cul-
ture  media and supplements were from Life Technologies. 
  Lipofectamine 2000 was purchased from Invitrogen; all other 
chemicals were from Sigma-Aldrich. Data are presented as mean 
± SEM. Two-sample comparisons were made using Student’s 
t test. For datasets containing more than two groups, an ANOVA 
was used. A P value of <0.05 was considered signifi  cant. The aster-
isk (*) symbol used in the fi  gures denotes a signifi  cant difference 
between groups.
Online Supplemental Material
The online supplemental material (Figs. S1 and S2, available at 
http://www.jgp.org/cgi/content/full/jgp.200609519/DC1) pro-
vides an example of our Ca2+ sparklet activity analysis.
RESULTS
Cavα1.2 Channels Produce Ca2+ Sparklets
All experiments in this study were performed in the 
presence of the SERCA pump inhibitor thapsigargin 
(1  μM) to eliminate Ca2+ release from intracellular 
stores. TIRF microscopy was used to image Ca2+ spar-
klet events with high spatial and temporal resolution. 
To increase the driving force for Ca2+ entry, experi-
ments were performed in the presence of 20 mM exter-
nal Ca2+ while cells were held at −70 mV. Analogous to 
single-channel data analysis, we determined the activity 
of Ca2+ sparklets by calculating the nPs of each sparklet 
site as described in the Materials and Methods.
First, we tested the hypothesis that L-type Ca2+ chan-
nels underlie Ca2+ sparklet activity in arterial myocytes. 
If L-type Ca2+ channels underlie Ca2+ sparklets, then 
Ca2+ sparklets should be observed in a heterologous 
  expression system expressing these channels. Thus, we 
examined Ca2+ sparklet activity in tsA-201 cells express-
ing the L-type Ca2+ channel pore-forming Cavα1.2 and 
accessory Cavβ3 and Cavα2δ1 subunits. Cavα1.2 chan-
nels are the predominant L-type Ca2+ channels ex-
pressed in arterial smooth muscle (Koch et al., 1990; 
Sinnegger-Brauns et al., 2004). To prevent any potential 
effect of endogenous PKC activity on Cavα1.2 function, 
these experiments were performed using the PKC 
  inhibitory peptide (100 μm) in the pipette solution.
To verify that tsA-201 cells transfected with Cavα1.2, 
Cavβ3, and Cavα2δ1 expressed functional channels, 
we depolarized these cells from −70 to +20 mV. As 
shown in Fig. 1 A, this protocol evoked robust Ca2+ 
currents in these cells. Ca2+ currents were not detected 
in nontransfected cells (n = 25). In addition, in tsA-
201 cells expressing Cavα1.2, Ca2+ sparklets were ob-
served at −70 mV (Fig. 1 B). Ca2+ sparklets were never 
observed in nontransfected cells (n = 25). As shown in 
the amplitude histogram in Fig. 1 C, the distribution of 
Figure 1.  Ca2+ sparklets in a heterologous expression system. 
(A) Ca2+ current evoked by a depolarization from −70 to +20 mV 
in a representative nontransfected (control) cell and cell express-
ing Cavα1.2. (B) Image of a cell transfected with Cavα1.2 only. 
The traces below the images show the time course of [Ca2+]i 
in the sites marked by the green circle before and after the appli-
cation of 500 nM Bay-K 8644. (C) Amplitude histogram of Ca2+ 
sparklets in tsA-201 cells expressing Cavα1.2 before and after Bay-K 
8644 treatment. The black and red lines are the best fi  t to the 
control (q = 37 nM) and Bay-K 8644 (q = 37 nM) data, respec-
tively, with the multicomponent Gaussian function described in 
the Materials and Methods section. (D) Bar plot of the mean ± 
SEM of the nPs before and after Bay-K 8644 application. 614 Local Control of Ca2+ Sparklets
Ca2+   sparklet amplitudes in tsA-201 cells was modal. 
Indeed, the data could be fi  t with a multicomponent 
Gaussian function with a quantal unit of Ca2+ elevation 
of 37.9 nM (χ2 = 0.76). Interestingly, the amplitude of 
quantal Ca2+ sparklets in these cells is similar to that 
reported in arterial myocytes (≈38 nM) under identi-
cal experimental conditions (Navedo et al., 2005). This 
analysis suggests that, as with Ca2+ sparklets recorded 
in arterial myocytes, Ca2+ entry via heterologuosly ex-
pressed Cavα1.2 channels is quantal in nature and that 
the size of Ca2+ sparklet depends on the number of 
quanta activated.
Detailed analysis revealed that the activity of Ca2+ 
sparklets sites in these cells had a mean nPs value of 
0.05 ± 0.02 (n = 9) (Fig. 1 D). This nPs value is similar 
(P  > 0.05) to that of low activity Ca2+ sparklet sites 
  reported in rat arterial myocytes (see also new data from 
rat and mouse myocytes presented below) (Navedo 
et al., 2005). Indeed, it is important to note that high 
activity, persistent Ca2+ sparklet sites (nPs > 0.2) were 
never observed in tsA-201 cells expressing Cavα1.2 only.
In rat arterial myocytes, Bay-K 8644 increases Ca2+ 
  infl  ux, at least in part, by increasing persistent Ca2+ 
  sparklet activity (Navedo et al., 2005). However, the 
mechanisms by which Bay-K 8644 increases persistent 
Ca2+ sparklet activity are unclear. We investigated 
whether Bay-K 8644 could induce persistent Ca2+ spar-
klet activity in tsA-201 cells expressing Cavα1.2 (Fig. 1, 
B–D). Application of 500 nM Bay-K 8644 recruited new 
Ca2+ sparklet sites and increased the activity of previ-
ously active sites. Indeed, Bay-K 8644 increased the 
  average Ca2+ sparklet activity (i.e., nPs) from 0.05 ± 0.03 
to 0.13 ± 0.04 (n = 6, P < 0.05; Fig. 1 D) without in-
creasing the amplitude of quantal Ca2+ sparklets (con-
trol = 37.0 nM vs. Bay-K 8644 = 37.6 nM; Fig. 1 C). 
Interestingly, even in the presence of 500 nM Bay-K 
8644 we did not detect high nPs, persistent Ca2+ spar-
klet sites in tsA-201 cells expressing Cavα1.2 only. These 
data suggest that although Cavα1.2 channel can pro-
duce low activity Ca2+ sparklets sites, expression of these 
channels alone is not suffi  cient to produce persistent 
Ca2+ sparklet activity under control conditions or after 
Bay-K 8644 treatment.
Cavα1.2 and PKCα Are Required for Persistent Ca2+ 
Sparklet Activity
We recently observed that PKC activity is required for 
persistent Ca2+ sparklet activity in rat arterial myocytes 
(Navedo et al., 2005). Thus, we examined Ca2+ sparklet 
activity in tsA-201 cells expressing Cavα1.2 channels and 
PKCα (Fig. 2). We used PKCα in these experiments be-
cause this isoform is highly expressed in cerebral artery 
myocytes (but see below) (Pang et al., 2002; Wickman 
et al., 2003). Depolarization from the holding potential 
of −70 mV to +20 mV evoked large Ca2+ currents in 
tsA-201 expressing Cavα1.2 channels and PKCα (Fig. 2 A). 
Ca2+ currents were not observed in cells expressing 
PKCα alone (n = 28).
Figure 2.  Ca2+ sparklets in tsA-201 cells expressing Cavα1.2 and PKCα. (A) Ca2+ current evoked by a depolarization from −70 to +20 mV 
in representative cells expressing PKCα or PKCα and Cavα1.2. (B) Time course of [Ca2+]i in Ca2+ sparklet site before and after the 
  application of 10 μM nifedipine. (C) Time course of [Ca2+]i in Ca2+ sparklet site under control conditions and after perfusion with a so-
lution without Ca2+. (D) Amplitude histogram of Ca2+ sparklets in tsA-201 cells expressing Cavα1.2 and PKCα. The black line is the best 
fi  t to the data (q = 36 nM) with the multicomponent Gaussian function described in the Materials and Methods section. (E) Voltage de-
pendence of quantal Ca2+ sparklet amplitude in tsA-201 cells. Solid line is a linear fi  t to the data. The inset shows representative quantal 
Ca2+ sparklets recorded from tsA-201 cells expressing Cavα1.2 channels at −90 and −50 mV. The dotted lines mark the quantal level for 
Ca2+ sparklets at −90 and −50 mV.  Navedo et al. 615
Accordingly, Ca2+ sparklet sites were frequently ob-
served at −70 mV in tsA-201 cells expressing Cavα1.2 
channels and PKCα, but never in cells expressing PKCα 
alone (n = 28). To provide further support to the hy-
pothesis that Ca2+ sparklets are produced by Ca2+ in-
fl  ux via Cavα1.2 channels and not Ca2+ release from a 
thapsigargin-insensitive intracellular Ca2+ store in tsA-
201 cells, we examined the effects of the L-type Ca2+ 
channel blocker nifedipine, which blocks sparklets in 
arterial myocytes (Navedo et al., 2005), and removing 
external Ca2+ on Ca2+ sparklets. As shown in Fig. 2 B, 
nifedipine completely eliminated Ca2+ sparklet activity 
(n = 15). Furthermore, we found that perfusion of an 
external solution with 0 Ca2+ (without nifedipine) rap-
idly eliminated Ca2+ sparklet activity in tsA-201 cells ex-
pressing Cavα1.2 channels (n = 10; Fig. 2 C). Together 
with our observation that Ca2+ sparklets are only de-
tected in tsA-201 cells expressing Cavα1.2, these fi  nd-
ings support the hypothesis that Ca2+ sparklets in 
tsA-201 cells are produced by Ca2+ infl  ux events through 
plasma membrane Cavα1.2 channels.
An amplitude histogram of Ca2+ sparklets in tsA-201 
cells expressing Cavα1.2 channels and PKCα is shown 
in Fig. 2 D. The histogram was fi  tted (χ2 = 0.84) with a 
multicomponent Gaussian function with a quantal unit 
of Ca2+ elevation of 36.0 nM, a value that is similar to 
that of cells expressing Cavα1.2 alone (see Fig. 1 C 
above). We also investigated the effects of membrane 
potential on the amplitude of quantal Ca2+ sparklets in 
tsA-201 cells expressing Cavα1.2 and PKCα. The ampli-
tude of quantal Ca2+ sparklets at the voltages examined 
was obtained from the event amplitude histogram of 
all Ca2+ sparklets using the multi-Gaussian analysis de-
scribed above. The inset in Fig. 2 E shows two [Ca2+]i 
records from a representative cell with quantal Ca2+ 
sparklets at −90 and −50 mV. Note that the amplitude 
of these Ca2+ sparklets decreased as the driving force 
for Ca2+ entry was decreased by membrane depolariza-
tion from −90 to −50 mV. Indeed, as previously re-
ported in rat arterial myocytes (Navedo et al., 2005), the 
amplitude of quantal Ca2+ sparklets in tsA-201 cells de-
creased linearly over this range of potentials (Fig. 2 E), 
providing further support to the view that Ca2+ spark-
lets are produced by Ca2+ infl  ux via L-type Cavα1.2 
channels in the plasma membrane.
We analyzed the modalities of Ca2+ sparklet activity 
in tsA-201 cells expressing Cavα1.2 and PKCα (Fig. 3, 
A and C). Although most of the surface membrane in 
these cells did not show signs of Ca2+ infl  ux at −70 mV 
(i.e., nPs = 0), there were sites of low and high Ca2+ 
sparklet activity (Fig. 2, C and D). Because cells express-
ing Cavα1.2 alone did not have high nPs sites, the com-
bined nPs value of cells expressing Cavα1.2 and PKCα 
(0.16 ± 0.03, n = 12) was about threefold higher than 
in cells expressing Cavα1.2 alone (0.05 ± 0.02, n = 6, 
P < 0.05). These data suggest that Ca2+ sparklets in 
tsA-201 expressing Cavα1.2 and PKCα and rat arterial 
myocytes have similar gating modalities.
The effects of Bay-K 8644 on Ca2+ sparklets in tsA-201 
cells expressing Cavα1.2 and PKCα were also investi-
gated (Fig. 3). Application of 500 nM Bay-K 8644 in-
creased the number of Ca2+ sparklet sites threefold 
Figure 3.  Cavα1.2 and PKCα are re-
quired for persistent Ca2+ sparklet 
  activity. (A) Image of tsA-201 cells 
expressing PKCα and Cavα1.2 with 
  silent, low, and high activity Ca2+ spar-
klet sites. The traces below the images 
show the time course of [Ca2+]i in the 
sites marked by the green circle before 
and after the application of 500 nM 
Bay-K 8644. (B) Amplitude histogram 
of Ca2+ sparklets in tsA-201 cells ex-
pressing Cavα1.2 and PKCα before and 
after Bay-K 8644 treatment. The black 
and red lines are the best fi  t to the con-
trol (q = 38 nM) and Bay-K 8644 (q = 
37 nM) data, respectively, with a multi-
component Gaussian function. (E) Bar 
plot of the mean ± SEM nPs under 
control conditions and after applica-
tion of Bay-K 8644 or nifedipine. 616 Local Control of Ca2+ Sparklets
(n = 8). Consistent with this, Bay-K 8644 activated qui-
escent Ca2+ channels in silent sites and increased Ca2+ 
sparklet activity in low nPs sites (P < 0.05), thus increas-
ing the number of high nPs, persistent Ca2+ sparklets in 
tsA-201 cells (Fig. 3, A–C). Bay-K 8644 did not increase 
Ca2+ sparklet activity in high nPs sites (P > 0.05), sug-
gesting maximal channel activity at these sites. Bay-K 
8644 increased the number of Ca2+ sparklets of all am-
plitude levels without altering the value of the quantal 
event (38.4 nM; Fig. 3 B). Importantly, the actions of 
Bay-K 8644 on Ca2+ sparklets in these cells are similar 
to those reported in arterial myocytes (Navedo et al., 
2005). Taken together, these data indicate that Ca2+ 
sparklets in tsA-201 cells expressing Cavα1.2 and PKCα 
have similar pharmacology, gating modalities, ampli-
tude of quantal event, and voltage dependencies than 
sparklets in arterial myocytes. This is consistent with 
the view that Cavα1.2 and PKCα are the minimal mo-
lecular components required for persistent Ca2+ spar-
klet activity under control conditions and after Bay-K 
8644 treatment.
Dynamic Modulation of Ca2+ Sparklet Activity 
Depends on the Relative Activities of PKCα 
and Opposing Phosphatases
Next, we investigated the mechanisms that underlie dy-
namic regional variations of persistent Ca2+ sparklet ac-
tivity in arterial myocytes. We tested the hypothesis that 
regional differences in Ca2+ sparklet activity result from 
regional differences in the relative activities of PKC, 
which we have shown here to be essential for persistent 
Ca2+ sparklet activity in tsA-201 cells, and nearby oppos-
ing phosphatases. To begin, we investigated which of the 
PKC isoforms expressed in cerebral arterial smooth mus-
cle are required for persistent Ca2+ sparklet activity. 
  Although the experiments described above indicate that 
expression of PKCα and Cavα1.2 channels is suffi  cient 
to reproduce the basic features of Ca2+ sparklets in tsA-
201 cells, two recent studies indicate that cerebral artery 
myocytes express three PKC isoforms: Ca2+-dependent 
PKCα and β and, to a lesser extent, the Ca2+-independent 
PKCε isoform (Pang et al., 2002; Wickman et al., 2003). 
We used isoform-specifi  c PKC inhibitors to determine 
which of these three PKC isoforms infl  uence persistent 
Ca2+ sparklet activity in cerebral arterial myocytes.
Like the experiments in tsA-201 cells, all experiments 
with arterial myocytes were performed with solutions 
containing the SERCA pump inhibitor thapsigargin 
(1  μM) to eliminate Ca2+ release from intracellular 
stores. To verify that Ca2+ sparklets were not produced 
by Ca2+ release from an intracellular store insensitive to 
thapsigargin, Ca2+ sparklets were recorded in rat arte-
rial myocytes under control conditions (i.e., 20 mM 
  external Ca2+ while the cells were held at −70 mV), in 
the presence of the dihydropyridine nifedipine and 
  after perfusion of a solution without Ca2+. As shown in 
Fig. 4 A, Ca2+ sparklets in arterial myocytes were com-
pletely abolished by the application of the dihydropyri-
dine nifedipine (10 μM; n = 7). Furthermore, note that 
Ca2+ sparklets were rapidly abolished by superfusion 
of a Ca2+-free solution (without nifedipine) (Fig. 4 B). 
Similar results were obtained in 10 independent experi-
ments. Together, these fi   ndings indicate that Ca2+ 
sparklets are produced by Ca2+ infl  ux via a sarcolemma 
L-type Ca2+ channel in arterial smooth muscle.
Fig. 4 (A and B, top traces) shows the time course of 
[Ca2+]i in a Ca2+ sparklet site from a representative rat 
arterial myocyte under control conditions. An ampli-
tude histogram of Ca2+ sparklets recorded under these 
conditions could be fi  t with a multi-Gaussian function 
with a quantal unit of Ca2+ increase of 37.5 nM (not 
  depicted), which is similar to that in tsA-201 cells 
Figure 4.  Basal PKCβ and PKCε activity is not required 
for Ca2+ sparklet activity in arterial smooth muscle. (A) 
Time course of [Ca2+]i in a Ca2+ sparklet site before and 
after the application of 10 μM nifedipine. (B) Time 
course of [Ca2+]i in a Ca2+ sparklet under control condi-
tions and after perfusion of a solution without Ca2+. 
Time course of [Ca2+]i in a Ca2+ sparklet site before and 
after the application of (C) 100 nM Gö6976 or (D) 50 
nM PKCβi. (E) Bar plot of the mean ± SEM nPs under 
control conditions and after application of Gö6976 or 
PKCβi. *, signifi  cantly different from control.   Navedo et al. 617
(see Fig. 1 C and Fig. 2 D above). We found that the ma-
jority of the sarcolemma of rat myocytes was optically 
  silent (i.e., nPs = 0). However, we observed foci of low 
(nPs = 0.06 ± 0.01, n = 75) and high (nPs = 0.7 ± 0.1, 
n = 58) Ca2+ sparklet activity. The average nPs value of 
Ca2+ sparklet sites under control conditions was 0.17 ± 
0.05 (n = 110). Interestingly, nPs values in rat arterial 
myocytes and tsA-201 cells (low nPs = 0.05 ± 0.01, high 
nPs = 0.6 ± 0.01, average nPs = 0.14 ± 0.04) expressing 
Cavα1.2 and PKCα were similar (P > 0.05).
Application of Gö6976 (100 nM), which selectively 
inhibits PKCα and PKCβ (Gschwendt et al., 1996), 
eliminated (i.e., nPs = 0, number of sparklet sites = 0) 
Ca2+ sparklet activity in rat arterial myocytes (Fig. 4, C–E). 
This suggests that the Ca2+-dependent PKCα and/or 
PKCβ isoforms underlie spontaneous persistent Ca2+ 
sparklet activity in rat arterial myocytes. To distinguish 
which of these two isoforms underlie spontaneous Ca2+ 
sparklet activity in these cells, we recorded Ca2+ spark-
lets before and after the application of a specifi  c PKCβ 
inhibitor (PKCβi, 50 nM) (Tanaka et al., 2004). In con-
trast to Gö6976, the averaged Ca2+ sparklet activity did 
not change after PKCβi application (control nPs = 0.21 ± 
0.04, n = 15 vs. PKCβi nPs = 0.29 ± 0.08, n = 15; P > 
0.05) (Fig. 4, D and E). In addition, we found that Ca2+ 
sparklet activity and the number of Ca2+ sparklet sites 
per cell were not changed by dialysis with a specifi  c 
PKCε inhibitory peptide (PKCεi) (Johnson et al., 1996) 
(unpublished data, n = 5 cells, P > 0.05). These data 
indicate that neither PKCβ nor PKCε activity is re-
quired for spontaneous Ca2+ sparklet activity in arterial 
smooth muscle.
By excluding PKCβ and PKCε, our data suggest that 
PKCα is required for Ca2+ sparklet activity in arterial 
myocytes. To directly test this hypothesis, we examined 
Ca2+ sparklet activity in mouse wild-type (WT) and 
PKCα knockout (PKCα−/−) (Braz et al., 2004) arterial 
myocytes. Fig. 5 (A and C) shows that mouse arterial 
myocytes produce Ca2+ sparklets. Indeed, it is impor-
tant to note that Ca2+ sparklets in WT mouse myocytes 
were similar (P > 0.05) to those in tsA-201 cells and rat 
arterial myocytes in all parameters examined (i.e., am-
plitude of the quantal events, 38 nM, and activity 
  modalities). Control mouse-WT myocytes had silent (i.e., 
nPs = 0) as well as low (nPs = 0.08 ± 0.02, n = 35) and 
high activity (nPs = 0.80 ± 0.30, n = 15) Ca2+ sparklet 
sites. Like rat arterial myocytes (Navedo et al., 2005), 
application of the broad-spectrum PKC activator phor-
bol 12, 13-dibutyrate (PDBu, 200 nM) increased Ca2+ 
infl  ux in mouse arterial myocytes by activating new Ca2+ 
sparklet sites and by increasing the activity of previously 
active sites (unpublished data). Indeed, PDBu increased 
the number of Ca2+ sparklet sites in mouse arterial myo-
cytes twofold (n = 7). Thus, persistent Ca2+ sparklets 
and their modulation by PKC appears to be a conserved 
feature of arterial myocytes.
Consistent with our data from rat arterial myocytes 
and tsA-201 cells, we found that PKCα−/− myocytes were 
devoid of persistent Ca2+ sparklet activity under control 
conditions (n = 20 cells). Indeed, in only 1 out of 20 
cells examined was a single Ca2+ sparklet event (ampli-
tude = 38 nM) evident at −70 mV.  Interestingly, appli-
cation of 200 nM PDBu, which would activate other PKC 
isoforms expressed in PKCα−/− cells, had a small effect 
Figure 5.  PKCα is required for Ca2+ sparklets in arterial 
smooth muscle. Sample images of typical WT (A) and 
PKCα−/− (B and C) mouse arterial myocytes. The traces be-
low the images (A and C) show the time course of [Ca2+]i in 
the sites marked by the green circle before and after the ap-
plication of 200 nM PDBu. (D) Bar plot of the mean ± SEM 
nPs under control conditions and after application of PDBu. 
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on Ca2+ sparklet activity in these cells, only activating a 
few, low nPs Ca2+ sparklet sites (nPs = 0.02 ± 0.01, n = 21; 
Fig. 5, B–D). In total, three Ca2+ sparklet sites were 
  observed in PKCα−/− cells in the presence of PDBu. In 
PKCα−/− cells, Ca2+ sparklet amplitudes ranged from 
34 to 41 nM. Note that this range of amplitudes is simi-
lar to the amplitude of quantal Ca2+ sparklets in WT 
mouse and rat myocytes and tsA-201 cells, indicating 
that the probability of coincidental openings of nearby 
L-type Ca2+ channels in PKCα−/− cells was low. Indeed, 
the effects of PDBu on Ca2+ sparklet activity in PKCα−/− 
cells (nPs ≈ 0.02 ± 0.01, n = 21) were 15-fold smaller 
than in WT cells (nPs = 0.30 ± 0.1, n = 15) (Fig. 5 D).   
Taken together, these data support the hypothesis that 
basal PKCα activity is necessary for spontaneous Ca2+ 
sparklet activity. Furthermore, our data suggest that re-
gional variations in the activity of PKCα underlie het-
erogeneous Ca2+ sparklet activity in arterial myocyte.
Having established that basal PKCα activity is neces-
sary for spontaneous persistent Ca2+ sparklet activity in 
arterial myocytes, we investigated the role of protein 
phosphatases in modulating the activity of these Ca2+ 
infl  ux events. Recent studies have suggested that the 
serine/threonine phosphatases PP1, PP2A, and PP2B 
modulate L-type Ca2+ channel function (Santana 
et al., 2002; duBell and Rogers, 2004). Thus, we tested 
the hypothesis that local variations in the relative activ-
ities of PKCα and opposing protein phosphatases de-
termine regional variations in Ca2+ sparklet activity in 
arterial myocytes.
First, we examined the role of PP2B (calcineurin) on 
Ca2+ sparklets (Fig. 6). Inhibition of PP2B with cyclo-
sporine A (CsA; 500 nM) increased Ca2+ infl  ux by ac-
tivation of previously silent sites and by increasing the 
activity of low activity sites (Fig. 6, A and C). CsA did not 
increase the activity of high nPs sites, suggesting maxi-
mal activity at these sites (Fig. 6, A and C). CsA induced 
a twofold increase in the number of Ca2+ sparklet sites 
per cell (n = 12, P < 0.05). The quantal amplitude of 
Ca2+ sparklets was unchanged by CsA (Fig. 6 D). It is im-
portant to note that CsA failed to activate Ca2+ sparklets 
in cells dialyzed with the PKC inhibitor PKCi (Fig. 6 B). 
These results suggest that PP2B dampens Ca2+ sparklet 
activity by opposing PKC-mediated phosphorylation.
Next, we investigated the effects of the PP1 and PP2A 
inhibitor calyculin A (100 nM) (duBell et al., 2002) on 
Ca2+ sparklets. Like CsA, calyculin A increased Ca2+ in-
fl  ux by activating previously silent Ca2+ sparklet sites 
and by increasing the activity of low nPs sites (Fig. 7, A 
and C). Again, the activity of high nPs sites did not 
change upon application of calyculin A, suggesting 
maximal activity at these sites. Calyculin A induced a 
2.3-fold increase in the number of Ca2+ sparklets sites 
per cell (n = 7, P < 0.05). As with CsA, calyculin A did 
not activate Ca2+ sparklets in cells dialyzed with PKCi 
(Fig. 7 B). These results suggest that PP1 and/or PP2A 
modulate Ca2+ sparklets by opposing PKC.
We used different concentration of okadaic acid (OA) 
to determine the relative contribution of PP1 and PP2A 
to Ca2+ sparklet activity (Fig. 8). At concentrations 
Figure 6.  PP2B opposes PKC-dependent 
activation of Ca2+ sparklets. (A) Images of 
representative cells with silent (left), low 
(center), and high (right) nPs sites. Traces 
below the images show the time course 
of [Ca2+]i in the green circle before 
(top) and after (bottom) application of 
500 nM cyclosporine A (CsA). (B) Sample 
  image from a cell dialyzed for 10 min with 
an   internal solution containing PKCi 
(100 μM) before and after CsA. The time 
course of [Ca2+]i in the region marked by 
the green circle is shown below the image. 
(C) Mean ± SEM nPs of Ca2+ sparklet sites 
in control conditions and in the   presence 
of CsA or PKCi and CsA. (D) Mean ± SEM 
amplitude of quantal Ca2+ sparklets before
and after application of CsA. *, signifi  -
cantly different from control.   Navedo et al. 619
of between 1 and 10 nM, OA inhibits PP2A, while 
at concentrations >100 nM, it blocks PP2A and PP1 
(Bialojan and Takai, 1988; duBell and Rogers, 2004). 
Application of 1 nM OA increased Ca2+ sparklet activity 
nearly twofold (Fig. 8 A). It is important to note that 
the increase in Ca2+ sparklet activity produced by 1 nM 
OA was not signifi  cantly different from that observed 
with calyculin A (P > 0.05). At 1 nM, OA induced a 2.5-
fold increase in the number of Ca2+ sparklets sites per 
cell (n = 9, P < 0.05). These data suggest that calyculin 
A increased Ca2+ sparklet activity by inhibiting PP2A. 
Consistent with this hypothesis, increasing OA in the 
bath from 1 to 100 nM, thus also inhibiting PP1, did not 
elicit any further increase in Ca2+ sparklet activity (nPs = 
0.37 ± 0.1, n = 31, P > 0.05) or sparklet density (n = 9, 
P > 0.05). As with CsA and calyculin A, OA did not acti-
vate Ca2+ sparklets in cells dialyzed with PKCi and did 
not change the quantal level of the Ca2+ sparklets (Fig. 
8). From these data we conclude that PP2A, PP2B, 
and PKCα form a signaling module that tunes local 
Ca2+ infl  ux via L-type Ca2+ channels in arterial smooth 
muscle cells.
DISCUSSION
We used TIRF microscopy to investigate with high reso-
lution the spatiotemporal organization of functional 
Ca2+ channels. Using this approach, we provide the fi  rst 
direct demonstration that persistent Ca2+ sparklet activ-
ity is a fundamental property of L-type Ca2+ channels 
when associated with PKC. Furthermore, we describe a 
novel mechanism for the local, dynamic control of 
steady-state Ca2+ infl  ux via L-type Ca2+ channels. We 
found that PKCα and the phosphatases PP2A and PP2B 
(calcineurin) have opposing effects on persistent Ca2+ 
sparklet activity. Our results also suggest that PP2A and 
PP2B oppose the actions of PKCα on L-type Ca2+ 
  channels. Based on these fi  ndings we propose that the 
degree of steady-state Ca2+ infl  ux in various regions of 
the cell via L-type Ca2+ channels is determined by a 
local balance between PKCα, PP2A, and PP2B activities.
Our data, in conjunction with earlier studies (Nelson 
et al., 1995), suggest that smooth muscle cells are capa-
ble of generating multiple types of local Ca2+ signals. 
For example, simultaneous activation of a small cluster 
of ryanodine-sensitive Ca2+ channels in the sarcoplas-
mic reticulum of these cells produces Ca2+ sparks 
(Nelson et al., 1995). Because Ca2+ sparks are produced 
by the release of Ca2+ from intracellular stores, they are 
insensitive to dihydropyridines or the removal of exter-
nal Ca2+, their amplitude is independent of changes in 
membrane voltage, and they are abolished by depleting 
the SR of Ca2+ with thapsigargin (Cannell et al., 1995; 
López-López et al., 1995; Nelson et al., 1995). In sharp 
contrast to Ca2+ sparks, the Ca2+ sparklets described 
here meet all the criteria for a Ca2+ infl  ux event via sar-
colemmal Ca2+ channels. First, Ca2+ sparklets are insen-
sitive to thapsigargin. Second, Ca2+ sparklets are rapidly 
eliminated by perfusion with a Ca2+-free solution. Third, 
the amplitude of quantal Ca2+ sparklets decreased with 
membrane depolarization (i.e., decreased driving 
force). Fourth, a dihydropyridine antagonist and ago-
nist inhibited and activated Ca2+ sparklets, respectively. 
Taken together, these data provide compelling support 
to the hypothesis that Ca2+ sparklets are produced by 
Ca2+ infl  ux via sarcolemma Ca2+ channels.
Figure 7.  Calyculin A increases Ca2+ 
sparklet activity. (A) Time course of 
[Ca2+]i in silent (left), low (center), and 
high (left) nPs sites from a representa-
tive cell before (top) and after (bottom) 
application of 100 nM calyculin A. (B) 
Sample image from a typical cell dia-
lyzed for 10 min with an internal solu-
tion containing PKCi (100 μM). The 
traces below show the time course of 
[Ca2+]i in the region of the cell marked 
by the green circle before (top trace) 
and after (bottom trace) calyculin A. 
(C) Mean ± SEM nPs before and after 
application of calyculin A or PKCi plus 
calyculin A. (D) Mean ± SEM amplitude 
of quantal Ca2+ sparklets before and 
  after application of calyculin A. *, signifi  -
cantly different from control. 620 Local Control of Ca2+ Sparklets
Our data unequivocally demonstrate that L-type 
Cavα1.2 channels have the ability to produce persistent 
Ca2+ sparklets even at hyperpolarized potentials 
(−70 mV). Interestingly, L-type Cavα1.2 channels require 
PKCα activity to operate in a persistent gating mode; in 
the absence of PKCα activity, Ca2+ sparklet activity in tsA-
201 cells and arterial myocytes at −70 mV was very low. 
An important fi  nding in our study is that heterologous 
expression of PKCα and Cavα1.2 channels was suffi  cient 
to reproduce all the basic features (i.e., amplitude of quan-
tal event, voltage dependencies, gating modalities, and 
pharmacology) of persistent Ca2+ sparklet activity in arte-
rial myocytes. These results strongly support the hypothesis 
that, as in heart (Wang et al., 2001), L-type Ca2+ channels 
underlie Ca2+ sparklets in arterial smooth muscle.
The data presented here, and in our previous study 
(Navedo et al., 2005), indicate that Ca2+ sparklets in 
arterial smooth muscle are produced by the opening 
of a single or a cluster of L-type Ca2+ channels. Accord-
ingly, simultaneous recordings of single Ca2+ channel 
currents and Ca2+ sparklets under conditions similar 
to those used in the current study (i.e., −70 mV and 
20 mM external Ca2+) demonstrated that an opening 
of a single Ca2+ channel (0.5 pA) could produce a Ca2+ 
sparklet of an amplitude of ≈37 nM (Navedo et al., 
2005). Because Ca2+ sparklet amplitude is variable (be-
tween 38 and 300 nM), these data strongly suggest that 
Ca2+ sparklets could be produced by the opening of a 
single or a cluster of L-type Ca2+ channels. Consistent 
with this, the all-points (see Fig. S1, available at http://
www.jgp.org/cgi/content/full/jgp.200609519/DC1) 
and event histograms (e.g., Fig. 1 C, Fig. 2 D, and Fig. 3 B) 
presented here clearly show well-defi  ned peaks with a 
quantal unit of Ca2+ infl  ux of  34–37 nM. Together, 
these data provide compelling support to the view that 
openings of a single or a cluster of L-type Ca2+ channels 
underlie Ca2+ sparklets in arterial smooth muscle.
Although Ca2+ sparklets in cardiac and smooth mus-
cle are produced by the same molecular entity (hence 
the same name), there are important differences be-
tween Ca2+ sparklets in these cells. For example, as 
noted above, Ca2+ sparklets in arterial myocytes are pro-
duced by the opening of a single or a cluster of L-type 
Cavα1.2 channels. In contrast, Ca2+ sparklets in ventric-
ular myocytes are produced by the opening of a single 
L-type Ca2+ channel (Wang et al., 2001). Furthermore, 
unlike smooth muscle, persistent Ca2+ sparklet activity 
has not been observed in ventricular myocytes. This is 
interesting because PKCα is expressed in ventricular 
myocytes (Braz et al., 2004) and Cavα1.2 is the predom-
inant Cavα isoform in these cells. Although the reasons 
for these differences are presently unclear, it is intrigu-
ing to speculate that basal PKCα activity in ventricular 
myocytes is lower than in arterial myocytes, thus de-
creasing the probability of persistent Ca2+ sparklet activ-
ity in these cells. This hypothesis is supported by our 
data suggesting that Ca2+ sparklet activity in tsA-201 ex-
pressing Cavα1.2 only and PKCα−/− myocytes, as in ven-
tricular myocytes, is low and mostly resulting from the 
activation of single Cavα1.2 channels. Future studies 
should examine the mechanisms modulating Ca2+ 
  sparklet activity in heart.
A recent study (Yang et al., 2005) provides insight into 
the molecular mechanisms underlying PKC-induced 
modulation of Ca2+ sparklet activity. Yang and cowork-
ers found that PKC could directly phosphorylate serine 
1928 of Cavα1.2 channels. Thus, it is intriguing to spec-
ulate that direct phosphorylation of this L-type Ca2+ 
channel subunit by PKC may play a critical role in the 
induction of persistent Ca2+ sparklet activity. Consistent 
with this, our data indicate that coexpression of Cavα1.2 
and PKCα is suffi  cient to produce persistent Ca2+ spar-
klet activity in tsA-201 cells. Future experiments should 
examine the molecular mechanisms by which PKCα 
promotes persistent L-type Ca2+ channel gating.
A particularly interesting fi  nding in this study is that 
inhibition of PP2A or PP2B increases Ca2+ infl  ux by re-
cruiting new Ca2+ sparklet sites and increasing the activ-
ity of low nPs sites. Inhibition of these phosphatases did 
not increase the activity of high nPs sites, indicating that 
these sites were maximally activated under control 
  conditions. These fi  ndings suggest that in silent Ca2+ spar-
klet sites, PP2A and/or PP2B activity is suffi  ciently high 
to exceed PKCα, thus favoring dephosphorylation of 
Ca2+ channels. Accordingly, in low nPs sites, the balance 
between PKCα and PP2A/PP2B favors submaximal 
PKCα-dependent phosphorylation, which induces low 
Ca2+ sparklet activity. In high nPs sites, however, PKCα 
activity exceeds PP2A/PP2B activity, thus favoring maxi-
mal phosphorylation of Ca2+ channels. Because silent, 
low, and high activity Ca2+ sparklet sites coexist in the 
same cell, these fi  ndings support a model in which Ca2+ 
infl   ux is determined locally by the relative balance 
Figure 8.  PP2A inhibits Ca2+ sparklets by opposing PKC. (A) 
Mean ± SEM nPs before and after application of 1 or 100 nM oka-
daic acid (OA) in the absence or presence of PKCi in the patch 
pipette. (B) Mean ± SEM amplitude of quantal Ca2+ sparklets 
  before and after application of 1 nM or 100 nM OA. *, signifi  cantly 
different from control.   Navedo et al. 621
  between PKCα-dependent phosphorylation and oppos-
ing phosphatases. Such a situation allows for dynamic, 
local modulation of Ca2+ channel gating modalities.
This model implies that when prevailing conditions 
favor dephosphorylation, Ca2+ infl   ux is most likely 
dominated by random, sporadic openings of solitary 
L-type Ca2+ channels. A physiological stimulus that in-
creases PKCα activity, or decreases the activity of PP2A 
and/or PP2B, would promote Ca2+ infl  ux via persistent 
Ca2+ sparklet sites. In this case, Ca2+ infl  ux would be 
determined by persistent Ca2+ channel activity in addi-
tion to rare, stochastic openings of these channels. 
  Accordingly, vasoactive agents that activate PKC (e.g., 
angiotensin II and UTP) would increase Ca2+ infl  ux 
and thereby constrict arterial smooth muscle, at least 
in part, by increasing persistent Ca2+ sparklet activity.
An issue that was not addressed by Navedo et al. 
(2005) is the mechanism by which Bay-K 8644 increases 
persistent Ca2+ sparklet activity in arterial myocytes. To 
our knowledge, Bay-K 8644 does not directly activate 
PKCα. Thus, how does Bay-K 8644 increase persistent 
Ca2+ sparklet activity in these cells? The experiments in 
this study provide insight into this issue. Note that Bay-K 
8644 induced high nPs, persistent Ca2+ sparklet activity 
in tsA-201 cells expressing Cavα1.2 and PKCα; persis-
tent Ca2+ sparklet activity was never observed after Bay-K 
8644 in tsA-201 cells expressing Cavα1.2 only. Based on 
these data, we propose a positive feedback model to 
  explain this apparent discrepancy between the effects of 
Bay-K 8644 on Ca2+ sparklets in tsA-201 cells and arte-
rial myocytes. In this model, application of Bay-K 8644 
(or any other Ca2+ channel opener) to arterial myocytes 
causes an increase in Ca2+ infl  ux (i.e., by increasing 
the mean open time and/or open probability of L-type 
Ca2+ channels) that would activate nearby Ca2+-sensitive 
PKCα. Once activated, this kinase can induce L-type 
Ca2+ channels to operate in a persistent gating mode, 
thus causing further Ca2+ infl  ux, which could presum-
ably maintain PKCα activity and hence persistent Ca2+ 
sparklet activity. Because PKC expression in arterial 
  myocytes is punctate (Maasch et al., 2000; Navedo et al., 
2005), PKCα and persistent Ca2+ sparklet activity does 
not propagate throughout the cell. As noted above, pro-
tein phosphatases provide additional negative control 
to this system. An interesting implication of this model 
is that while Ca2+ sparklets could be evoked by voltage 
or pharmacological means wherever Cavα1.2 channels 
are expressed, persistent Ca2+ channel activity would 
only occur in regions of the cell membrane where both 
Cavα1.2 and PKCα are expressed. Future experiments 
should investigate the spatial and temporal relationship 
between Ca2+ sparklets and PKCα in arterial myocytes.
To conclude, we demonstrated that persistent Ca2+ 
sparklet activity is a fundamental feature of L-type 
Cavα1.2 channels in association with PKCα. Because 
PKC and Cavα1.2 are ubiquitously expressed, our fi  nd-
ings support the concept that Ca2+ infl  ux via persistent 
L-type Ca2+ channels may represent a general mecha-
nism for the control of steady-state Ca2+ infl  ux  in 
  excitable cells.
Furthermore, our observations support the concept 
that PKCα, PP2A, and PP2B form a signaling module 
that tunes the activity of Ca2+ channels, allowing for 
  local, dynamic regulation of steady-state Ca2+ infl  ux in 
cerebral arterial smooth muscle and perhaps excitable 
cells in general.
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